STEMIMMUNE INCORPORATED has a total of 15 patent applications. Its first patent ever was published in 2015. It filed its patents most often in Mexico, Canada and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are VIROMETIX AG, OURO FINO SAÚDE ANIMAL LTDA and INST OF BASIC MEDICINE CHINESE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Mexico | 3 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | United States | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Szalay Aladar | 11 |
#2 | Minev Boris | 11 |
#3 | Aladar Szalay | 4 |
#4 | Boris Minev | 4 |
Publication | Filing date | Title |
---|---|---|
CN108135996A | To the antismallpox vaccine for the treatment of of cancer | |
AU2016232863A1 | Virotherapy with an antibody combination |